Charles River Laboratories | CRL - Eps Gewinn Pro Aktie

Aktienkurs
168.27
Täglich Wechseln
0.05 0.03%
Monatlich
-4.93%
Jährlich
36.13%
Q2 Prognose
168.66

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.93 2.34 May/07
FY2025Q4 Dec/2025 2.39 2.35 2.66 Feb/18
FY2025Q3 Sep/2025 2.43 2.34 2.59 Nov/05
FY2025Q2 Jun/2025 3.12 2.48 2.80 Aug/06
FY2025Q1 Mar/2025 2.34 2.13 2.27 May/07




Eps Veränderung Datum
Agilent USD 1.32 0.35 2025-12
Align Technology USD 3.29 0.68 2025-12
Bio-Rad Laboratories USD 2.51 0.25 2025-12
Bruker USD 0.59 0.14 2025-12
Cardinal Health USD 2.63 0.08 2025-12
Charles River Laboratories USD 2.39 0.04 2025-12
Cigna USD 8.08 0.25 2025-12
Concord Medical Services Hldg CNY -0.21 0.49 2025-06
CVS Health USD 1.09 0.51 2025-12
Danaher USD 2.23 0.34 2025-12
Dentsply International USD 0.06 0.44 2025-12
Elevance Health USD 3.33 2.7 2025-12
Galapagos EUR 11.89 12.3 2025-12
Hologic USD 1.04 0.09 2025-12
Humana USD -3.96 7.2 2025-12
Illumina USD 1.35 0.01 2025-12
Incyte USD 1.8 0.46 2025-12
Intrexon USD -0.1 0.03 2024-06
IQVIA Holdings USD 3.42 0.42 2025-12
Laboratory Of America USD 4.07 0.11 2025-12
Lonza CHF 6.07 1.92 2025-06
McKesson USD 9.34 0.52 2025-12
Merck EUR 1.88 0.44 2025-12
Mettler Toledo International USD 13.36 2.21 2025-12
Novartis USD 1.54 0.5 2025-12
Pfizer USD 0.66 0.21 2025-12
Quest Diagnostics USD 2.42 0.18 2025-12
Revvity USD 1.7 0.52 2025-12
Thermo Fisher Scientific USD 6.57 0.78 2025-12
United Therapeutics USD 7.7 0.54 2025-12
UnitedHealth USD 2.11 0.81 2025-12
Veradigm USD -0.34 0.46 2022-12
Waters USD 4.53 1.13 2025-12
West Pharmaceutical Services USD 2.04 0.08 2025-12